{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:35:32Z","timestamp":1789821332104,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ejmech.2023.115375","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T19:59:42Z","timestamp":1681243182000},"page":"115375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Design, synthesis and biological evaluation of matrine-dithiocarbamate hybrids as potential anticancer agents"],"prefix":"10.1016","volume":"254","author":[{"given":"Meng-Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8706-911X","authenticated-orcid":false,"given":"Meng-Xue","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115375_bib1","first-page":"209","article-title":"Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: cancer. J. Clin."},{"key":"10.1016\/j.ejmech.2023.115375_bib2","first-page":"451","article-title":"Global Cancer Statistics 2022: the trends projection analysis","volume":"10","author":"Chhikara","year":"2023","journal-title":"Chem. Biol. Lett."},{"key":"10.1016\/j.ejmech.2023.115375_bib3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.ejmech.2023.115375_bib4","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.clinthera.2016.03.026","article-title":"Current challenges in cancer treatment","volume":"38","author":"Zugazagoitia","year":"2016","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.ejmech.2023.115375_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0145-2126(00)00145-4","article-title":"Effects of matrine on proliferation and differentiation in K-562 cells","volume":"25","author":"Zhang","year":"2001","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejmech.2023.115375_bib6","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1016\/j.bmcl.2012.04.069","article-title":"Synthesis, characterization and in vitro anti-tumor activities of matrine derivatives","volume":"22","author":"Wang","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115375_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ejmech.2018.10.037","article-title":"Research advances on anticancer activities of matrine and its derivatives: an updated overview","volume":"161","author":"Rashid","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115375_bib8","first-page":"284","article-title":"Synthesis and biological evaluation of novel hybrid matrine derivatives as anticancer agents","volume":"22","author":"He","year":"2012","journal-title":"Chin. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115375_bib9","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.bmcl.2015.04.051","article-title":"Design, synthesis and anticancer activity of matrine-1H-1,2,3-triazole-chalcone conjugates","volume":"25","author":"Zhao","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115375_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113682","article-title":"A review of its pharmacology, pharmacokinetics, toxicity, clinical application and preparation researches","volume":"269","author":"Li","year":"2021","journal-title":"J. Ethnopharmcol."},{"key":"10.1016\/j.ejmech.2023.115375_bib11","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.6023\/cjoc201504040","article-title":"Progress in the studies on synthesis and biological properties of dithiocarbamates","volume":"35","author":"Li","year":"2015","journal-title":"Chin. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2023.115375_bib12","article-title":"An insight into medicinal attributes of dithiocarbamates: bird's eye view","volume":"15","author":"Shinde","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115375_bib13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1021\/jm0508888","article-title":"Structure\u2212activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors","volume":"49","author":"Gaspari","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115375_bib14","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1016\/S0960-894X(98)00564-2","article-title":"The cruciferous phytoalexins brassinin and cyclobrassinin are intermediates in the biosynthesis of brassilexin","volume":"8","author":"Soledade","year":"1998","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.115375_bib15","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1016\/j.bmc.2010.04.091","article-title":"Synthesis, molecular modeling and biological evaluation of dithiocarbamates as novel antitubulin agents","volume":"18","author":"Qian","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115375_bib16","doi-asserted-by":"crossref","first-page":"9708","DOI":"10.1016\/j.bmc.2008.09.071","article-title":"Design, synthesis and antitumor evaluation of novel thalidomide dithiocarbamate and dithioate analogs against Ehrlich ascites carcinoma-induced solid tumor in Swiss albino mice","volume":"16","author":"Zahran","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115375_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107686","article-title":"The strategies and techniques of drug discovery from natural products","volume":"216","author":"Zhang","year":"2020","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ejmech.2023.115375_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187925","article-title":"Nature is the best source of anticancer drugs: indexing natural products for their anticancer bioactivity","volume":"12","author":"Rayan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2023.115375_bib19","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2023.115375_bib20","first-page":"2054","article-title":"Discovery of 2-indole-acylsulfonamide myeloid cell leukemia 1 (mcl-1)inhibitors using fragment-based methods","volume":"56","author":"Pelz","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115375_bib21","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2174\/1568026619666190619115735","article-title":"Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases","volume":"19","author":"Ivasiv","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115375_bib22","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s00044-019-02398-2","article-title":"Design, synthesis, and biological evaluation of matrine derivatives possessing piperazine moiety as antitumor agents","volume":"28","author":"Xu","year":"2019","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2023.115375_bib23","doi-asserted-by":"crossref","first-page":"7062","DOI":"10.1016\/j.tetlet.2009.09.172","article-title":"A simple approach for the synthesis of new classes of dithiocarbamate-linked peptidomimetics","volume":"50","author":"Hemantha","year":"2009","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2023.115375_bib24","first-page":"1897","article-title":"New synthetic method for dithiocarbamates","volume":"20","author":"Li","year":"1999","journal-title":"Chem. J. Chin. Univ."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423003410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423003410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:52:23Z","timestamp":1759330343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423003410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":24,"alternative-id":["S0223523423003410"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115375","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of matrine-dithiocarbamate hybrids as potential anticancer agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115375"}}